de Mendonça Fernandes, Glaucia Maria
Wang, Wesley
Ahmadian, Saman Seyed
Jones, Daniel
Peng, Jing
Giglio, Pierre
Venere, Monica
Otero, José Javier
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R03NS116334)
National Institute of Health/ National Heart, Lung, and Blood Institute (R01HL163965-01)
The Ohio State University Comprehensive Cancer Center Bioinformatics Shared Resource and Genomics Shared Resource supported by the National Cancer Institute (P30CA016058)
Ohio State University‐Translational Data Analytics Institute (OSU‐TDAI) seed grant (TL1TR002735)
National Center for Advancing Translational Sciences (UL1TR002733)
James Cancer Center - Neuro-Oncology Novel Therapies and Research Fund (GF314420)
Article History
Received: 14 June 2024
Accepted: 18 February 2025
First Online: 11 April 2025
Declarations
:
: All studies were conducted with the approval of the The Ohio State University (IRB study number 2020C0062).
: All authors have approved the manuscript and agree with its submission.
: The authors declare that they have no competing interests.